{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:19:46Z","timestamp":1790813986963,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","sfnmjournal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.siny.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T09:17:27Z","timestamp":1490260647000},"page":"220-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Persistent pulmonary hypertension of the newborn"],"prefix":"10.1016","volume":"22","author":[{"given":"Mamta","family":"Fuloria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy L.","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2017.03.004_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes","volume":"105","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib2","first-page":"157","article-title":"Diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"16","author":"Bendapudi","year":"2015","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.siny.2017.03.004_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.jp.7210908","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up","volume":"23","author":"Clark","year":"2003","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1067\/mpd.2000.104826","article-title":"Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS)","volume":"136","year":"2000","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpeds.2006.11.065","article-title":"Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up","volume":"150","author":"Konduri","year":"2007","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/oxfordjournals.bmb.a070439","article-title":"Pulmonary circulation in the foetus and new-born","volume":"22","author":"Dawes","year":"1966","journal-title":"Br Med Bull"},{"key":"10.1016\/j.siny.2017.03.004_bib7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/01.CIR.94.5.1068","article-title":"Role of the pulmonary circulation in the distribution of human fetal cardiac output during the second half of pregnancy","volume":"94","author":"Rasanen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.siny.2017.03.004_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0095-5108(18)30039-3","article-title":"Pulmonary vascular biology during neonatal transition","volume":"26","author":"Lakshminrusimha","year":"1999","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/cvr\/15.2.108","article-title":"Adaptation of the pulmonary circulation to extra-uterine life in the pig and its relevance to the human infant","volume":"15","author":"Haworth","year":"1981","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.siny.2017.03.004_bib10","doi-asserted-by":"crossref","first-page":"L361","DOI":"10.1152\/ajplung.2001.281.2.L361","article-title":"C-type natriuretic peptide system in fetal ovine pulmonary vasculature","volume":"281","author":"Lakshminrusimha","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.siny.2017.03.004_bib11","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1542\/peds.2006-3037","article-title":"Risk factors for persistent pulmonary hypertension of the newborn","volume":"120","author":"Hernandez-Diaz","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/sj.jp.7211673","article-title":"Characteristics of pulmonary hypertension in preterm neonates","volume":"27","author":"Kumar","year":"2007","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jpeds.2012.03.008","article-title":"Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure","volume":"161","author":"Aikio","year":"2012","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(80)80753-0","article-title":"Serum salicylate levels and right-to-left ductus shunts in newborn infants with persistent pulmonary hypertension","volume":"96","author":"Perkin","year":"1980","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.2012-0496","article-title":"Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn","volume":"131","author":"Van Marter","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1164\/rccm.200701-163OC","article-title":"Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat","volume":"176","author":"Fornaro","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.siny.2017.03.004_bib17","doi-asserted-by":"crossref","first-page":"H572","DOI":"10.1152\/ajpheart.00822.2015","article-title":"Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero","volume":"311","author":"Hooper","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.siny.2017.03.004_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"17","author":"Kallen","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.siny.2017.03.004_bib19","doi-asserted-by":"crossref","first-page":"e20160181","DOI":"10.1542\/peds.2016-0181","article-title":"Neonatal morbidity after maternal use of antidepressant drugs during pregnancy","volume":"138","author":"Norby","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib20","article-title":"SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn","author":"Berard","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2017.03.004_bib21","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2015.5605","article-title":"Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn","volume":"313","author":"Huybrechts","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.siny.2017.03.004_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1515\/JPM.2004.030","article-title":"Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn","volume":"32","author":"Shah","year":"2004","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.siny.2017.03.004_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00246-006-0011-6","article-title":"Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates","volume":"28","author":"Cua","year":"2007","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.siny.2017.03.004_bib24","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00431-010-1200-0","article-title":"Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome","volume":"169","author":"Weijerman","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpeds.2007.05.054","article-title":"ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn","volume":"151","author":"Kunig","year":"2007","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000101347","article-title":"Genetic disorders of surfactant proteins","volume":"91","author":"Hamvas","year":"2007","journal-title":"Neonatology"},{"key":"10.1016\/j.siny.2017.03.004_bib27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa032178","article-title":"ABCA3 gene mutations in newborns with fatal surfactant deficiency","volume":"350","author":"Shulenin","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2017.03.004_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/pr.2011.24","article-title":"Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn","volume":"71","author":"Byers","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2017.03.004_bib29","doi-asserted-by":"crossref","first-page":"29877","DOI":"10.1038\/srep29877","article-title":"EDN1 Gene variant is associated with neonatal persistent pulmonary hypertension","volume":"6","author":"Mei","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.siny.2017.03.004_bib30","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM200106143442404","article-title":"Neonatal pulmonary hypertension\u2013urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function","volume":"344","author":"Pearson","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2017.03.004_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1164\/rccm.201010-1697CI","article-title":"Alveolar capillary dysplasia","volume":"184","author":"Bishop","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.siny.2017.03.004_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ppul.20244","article-title":"Persistent pulmonary hypertension of newborn due to congenital capillary alveolar dysplasia","volume":"40","author":"Singh","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.siny.2017.03.004_bib33","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajhg.2009.05.005","article-title":"Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations","volume":"84","author":"Stankiewicz","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.siny.2017.03.004_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/jp.2012.164","article-title":"Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia","volume":"33","author":"Check","year":"2013","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOP.0b013e328360a3f6","article-title":"Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond","volume":"25","author":"Mourani","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1172\/JCI105355","article-title":"Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes","volume":"45","author":"Rudolph","year":"1966","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.siny.2017.03.004_bib37","first-page":"657","article-title":"Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension","volume":"81","author":"Bifano","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib38","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1542\/peds.81.5.650","article-title":"Hearing loss in infants with persistent fetal circulation","volume":"81","author":"Hendricks-Munoz","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1203\/01.pdr.0000191136.69142.8c","article-title":"Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation","volume":"59","author":"Lakshminrusimha","year":"2006","journal-title":"Pediatr Res"},{"issue":"111","key":"10.1016\/j.siny.2017.03.004_bib40","first-page":"1441","article-title":"Pulmonary hemodynamics and vascular reactivity in asphyxiated term lambs resuscitated with 21 and 100% oxygen","volume":"2011","author":"Lakshminrusimha","year":"1985","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.siny.2017.03.004_bib41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.clp.2012.06.006","article-title":"The pulmonary circulation in neonatal respiratory failure","volume":"39","author":"Lakshminrusimha","year":"2012","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1203\/PDR.0b013e3181bab0c7","article-title":"Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension","volume":"66","author":"Lakshminrusimha","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2017.03.004_bib43","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/S0140-6736(10)60543-0","article-title":"Resuscitation of newborn infants: from oxygen to room air","volume":"376","author":"Saugstad","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.siny.2017.03.004_bib44","first-page":"S52","article-title":"Clinical approaches to the use of high-frequency oscillatory ventilation in neonatal respiratory failure","volume":"16","author":"Kinsella","year":"1996","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-3476(97)70124-0","article-title":"Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn","volume":"131","author":"Kinsella","year":"1997","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1542\/peds.97.1.48","article-title":"Surfactant replacement therapy for meconium aspiration syndrome","volume":"97","author":"Findlay","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib47","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2004.04.056","article-title":"Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia?","volume":"145","author":"Van Meurs","year":"2004","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib48","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/jp.2013.83","article-title":"Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term\/late preterm neonates with moderate hypoxic respiratory failure","volume":"33","author":"Konduri","year":"2013","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-3476(98)70482-2","article-title":"Group SiTIS: multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure","volume":"132","author":"Lotze","year":"1998","journal-title":"J\u00a0Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.siny.2017.03.004_bib50","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/jp.2016.44","article-title":"Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates","volume":"36","author":"Lakshminrusimha","year":"2016","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1542\/peds.101.3.325","article-title":"Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO\/PPHN Study Group","volume":"101","author":"Davidson","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM200002173420704","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group","volume":"342","author":"Clark","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2017.03.004_bib53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group","volume":"336","author":"Roberts","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2017.03.004_bib54","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term","volume":"4","author":"Finer","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2017.03.004_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/(SICI)1099-0496(199907)28:1<24::AID-PPUL5>3.0.CO;2-M","article-title":"Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn","volume":"28","author":"Dobyns","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.siny.2017.03.004_bib56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1542\/peds.113.3.559","article-title":"A\u00a0randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure","volume":"113","author":"Konduri","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/jp.2009.171","article-title":"Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension","volume":"30","author":"Gonzalez","year":"2010","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(00)03548-0","article-title":"Inhaled nitric oxide in neonates with persistent pulmonary hypertension","volume":"357","author":"Tworetzky","year":"2001","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.siny.2017.03.004_bib59","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/jp.2016.45","article-title":"Management of hypoxemic respiratory failure and pulmonary hypertension in preterm infants","volume":"36","author":"Ambalavanan","year":"2016","journal-title":"J\u00a0Perinatol"},{"issue":"Suppl 2","key":"10.1016\/j.siny.2017.03.004_bib60","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/jp.2016.46","article-title":"Management of pulmonary hypertension in infants with congenital diaphragmatic hernia","volume":"36","author":"Gien","year":"2016","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000542-199907000-00041","article-title":"Sildenafil ameliorates effects of inhaled nitric oxide withdrawal","volume":"91","author":"Atz","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.siny.2017.03.004_bib62","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1542\/peds.2005-0523","article-title":"Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study","volume":"117","author":"Baquero","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2017.03.004_bib63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0885066608321389","article-title":"Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease","volume":"23","author":"Lee","year":"2008","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.siny.2017.03.004_bib64","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.200605-694OC","article-title":"Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children","volume":"174","author":"Namachivayam","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.siny.2017.03.004_bib65","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jpeds.2009.06.012","article-title":"Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension","volume":"155","author":"Steinhorn","year":"2009","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.siny.2017.03.004_bib66","first-page":"CD005494","article-title":"Sildenafil for pulmonary hypertension in neonates","author":"Shah","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2017.03.004_bib67","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1203\/00006450-199508000-00011","article-title":"Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets","volume":"38","author":"Zobel","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2017.03.004_bib68","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1152\/jappl.1999.86.4.1160","article-title":"Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension","volume":"86","author":"Hill","year":"1999","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.siny.2017.03.004_bib69","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/oxfordjournals.eurheartj.a015478","article-title":"An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension","volume":"18","author":"Mikhail","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.siny.2017.03.004_bib70","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jtcvs.2003.11.035","article-title":"Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery","volume":"127","author":"De Wet","year":"2004","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.siny.2017.03.004_bib71","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.98.12040932","article-title":"Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension","volume":"12","author":"De Jaegere","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.siny.2017.03.004_bib72","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1067\/mpd.2002.129849","article-title":"Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide","volume":"141","author":"Kelly","year":"2002","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib73","doi-asserted-by":"crossref","first-page":"F214","DOI":"10.1136\/fn.71.3.F214","article-title":"Aerosolised prostacyclin for pulmonary hypertension in neonates","volume":"71","author":"Bindl","year":"1994","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.siny.2017.03.004_bib74","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s001340050498","article-title":"Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn","volume":"23","author":"Soditt","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.siny.2017.03.004_bib75","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ppul.22985","article-title":"Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn","volume":"49","author":"Kahveci","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.siny.2017.03.004_bib76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/PCC.0b013e3181936aee","article-title":"Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn","volume":"10","author":"Lakshminrusimha","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.siny.2017.03.004_bib77","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00003246-200003000-00031","article-title":"Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension","volume":"28","author":"Deb","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.siny.2017.03.004_bib78","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1152\/japplphysiol.01082.2009","article-title":"Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension","volume":"109","author":"Kumar","year":"2010","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.siny.2017.03.004_bib79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcrc.2006.01.001","article-title":"Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn","volume":"21","author":"McNamara","year":"2006","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.siny.2017.03.004_bib80","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PCC.0b013e31824ea2cd","article-title":"Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide","volume":"14","author":"McNamara","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.siny.2017.03.004_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000088192","article-title":"Neonatal persistent pulmonary hypertension treated with milrinone: four case reports","volume":"89","author":"Bassler","year":"2006","journal-title":"Biol Neonate"},{"key":"10.1016\/j.siny.2017.03.004_bib82","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1164\/ajrccm\/146.5_Pt_2.S56","article-title":"Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties","volume":"146","author":"Luscher","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.siny.2017.03.004_bib83","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1152\/jappl.1991.71.2.410","article-title":"Mechanisms by which endothelin 1 induces pulmonary vasoconstriction in the rabbit","volume":"71","author":"Mann","year":"1991","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.siny.2017.03.004_bib84","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1152\/jappl.1992.72.5.1730","article-title":"Endothelin-1-induced pulmonary arterial dilation is reduced by N omega-nitro-L-arginine in fetal lambs","volume":"72","author":"Tod","year":"1992","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.siny.2017.03.004_bib85","first-page":"H1965","article-title":"Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow","volume":"269","author":"Wong","year":"1995","journal-title":"Am J Physiol"},{"issue":"1 Suppl","key":"10.1016\/j.siny.2017.03.004_bib86","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1378\/chest.114.1_Supplement.65S","article-title":"Chronic intrauterine pulmonary hypertension increases preproendothelin-1 and decreases endothelin B receptor mRNA expression in the ovine fetal lung","volume":"114","author":"Ivy","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.siny.2017.03.004_bib87","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/pr.2012.177","article-title":"Endothelin-1 impairs angiogenesis in\u00a0vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep","volume":"73","author":"Gien","year":"2013","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2017.03.004_bib88","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0095-5108(18)30291-4","article-title":"Persistent pulmonary hypertension of the newborn: role of nitric oxide and endothelin in the pathophysiology and treatment","volume":"22","author":"Steinhorn","year":"1995","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib89","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2007-994352","article-title":"Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn","volume":"13","author":"Kumar","year":"1996","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib90","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.siny.2017.03.004_bib91","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/jp.2011.157","article-title":"A\u00a0randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn","volume":"32","author":"Mohamed","year":"2012","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2017.03.004_bib92","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpeds.2016.06.078","article-title":"Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn: results of the randomized multicenter placebo-controlled exploratory trial","volume":"177","author":"Steinhorn","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2017.03.004_bib93","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(96)04100-1","article-title":"UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.siny.2017.03.004_bib94","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.1542\/peds.2005-1167","article-title":"United Kingdom collaborative randomized trial of neonatal extracorporeal membrane oxygenation: follow-up to age 7 years","volume":"117","author":"McNally","year":"2006","journal-title":"Pediatrics"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X17300392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X17300392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T20:24:03Z","timestamp":1658867043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X17300392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1744165X17300392"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2017.03.004","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent pulmonary hypertension of the newborn","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}